Wuwei Heavy Ion Breaks International Monopoly and Achieves Leapfrog Progress
Wuwei Heavy Ion Breaks International Monopoly and Achieves Leapfrog Progress
— The Second Standardized Training Course on Proton and Heavy Ion Radiotherapy Technology Concludes Successfully in Wuwei
From September 26 to 28, the Second Standardized Training Course on Clinical Application of Restricted Medical Technologies – Standardized Training for Technicians in Proton and Heavy Ion Accelerator Radiotherapy was successfully held in Wuwei, Gansu. Hosted by the Chinese Medical Doctor Association (CMDA), it was co-organized by Wuwei Cancer Hospital (Gansu Province) and Tsinghua Big Health Team.
Yee-Min Jen , Former Chairman of the Taiwan Radiation Oncology Treatment Association and Specially Appointed Professor at Wuwei Cancer Hospital, chaired the first day of the program.
This academic gathering, which pooled top domestic expertise, not only nurtured professional talents for China’s national particle radiotherapy sector but also—through the practical achievements of the Wuwei Heavy Ion Center—showcased to the industry China’s historic leap from following international peers to leading globally in heavy ion therapy. It further injected strong momentum into advancing high-quality development of China’s particle medical industry.
As a high-level academic exchange platform in China’s particle radiotherapy sector, this training course gathered a stellar lineup of top domestic experts.
Academician Ma Jun of the Chinese Academy of Sciences led the lectures. Joining him were over a dozen leading figures in China’s particle therapy field—including Tang Jintian, Deputy Director of the Institute of Medical Physics and Engineering at Tsinghua University’s Department of Engineering Physics; Wu Xiaojin, Vice President of Xuzhou Central Hospital; Shi Pengyue from Shandong Cancer Hospital; and Wu Kailiang from Fudan University Shanghai Cancer Center—who, alongside Wuwei Cancer Hospital’s President Ye Yancheng, Vice President Zhang Yanshan, and Ma Xiaoyun, Director of the Radiation Physics Department, delivered in-depth sessions focusing on cutting-edge technologies such as heavy ion therapy, proton therapy, and BNCT (boron neutron capture therapy).
From the dimensions of technological R&D breakthroughs, clinical application practices, and standard system development, the experts systematically unpacked the latest achievements and trends in particle radiotherapy. They crafted an academic feast that blended theoretical rigor with practical value for all participants.
During his lecture, Professor Tang Jintian offered a sharply condensed assessment: “Wuwei is the Jinggangshan of China’s heavy ion therapy. Its arduous entrepreneurial journey has created countless miracles—and today, it continues to write new chapters of internationally leading heavy ion therapy breakthroughs.”
This remark not only affirms the development achievements of the Wuwei Heavy Ion Center but also precisely anchors its irreplaceable “benchmark status” in the history of China’s particle medicine.
Academician Ma Jun of the Chinese Academy of Sciences delivered a presentation titled "Scientific and Technological Innovation Guided by Clinical Problems – Cultivating Innovative Young Talents Through Projects"
Professor Tang Jintian, Deputy Director of the Institute of Medical Physics and Engineering at Tsinghua University’s Department of Engineering Physics, delivered a presentation titled "Advantages and Issues in the Development of China’s Advanced Particle Medical Industry"
Ye Yancheng, President of Wuwei Cancer Hospital (Gansu Province), delivered a presentation titled "New Advances in the Clinical Application of the First Domestically Developed Heavy Ion System"
Professor Zhang Yanshan, Vice President of Wuwei Cancer Hospital (Gansu Province), delivered a presentation titled "Heavy Ion Therapy for Abdominal and Pelvic Cancers
Professor Ma Xiaoyun, Director of the Radiation Physics Department at Wuwei Cancer Hospital (Gansu Province), delivered a presentation titled "Key Issues in Medical Physics for Advanced Particle Therapy"
Professor Wu Xiaojin, Vice President of Xuzhou Central Hospital, delivered a presentation titled "Overview of the Development of Heavy Ion Clinical Therapy"
Professor Shi Pengyue of Shandong Cancer Hospital delivered a presentation titled "Proton Therapy for Abdominal and Pelvic Cancers"
Professor Wu Kailiang of Fudan University Shanghai Cancer Center delivered a presentation titled "Proton Therapy for Head and Neck and Thoracic Cancers"
Professor Cheng Yufeng, Vice President of Qilu Hospital of Shandong University, delivered a presentation titled "Research Advances in BNCT Combined with Other Treatment Modalities"
Professor Cheng Yufeng, Vice President of Qilu Hospital of Shandong University, delivered a presentation titled "Research Advances in BNCT Combined with Other Treatment Modalities"
Professor Pan Jianji of Fujian Medical University delivered a presentation titled "BNCT Treatment for Malignant Brain Tumors"
Professor Mu Xiangkui of Shandong Cancer Hospital delivered a presentation titled "Overview of the Development of Clinical Proton Therapy"
Professor Tang Jintian, Deputy Director of the Institute of Medical Physics and Engineering at Tsinghua University’s Department of Engineering Physics, delivered a presentation titled "Construction of Particle Therapy Facilities and Configuration Certificate Application in China
Professor Gu Long from the School of Nuclear Science and Technology, Lanzhou University, delivered a presentation titled "Technological Innovation in Engineering for Precision Particle Therapy in Oncology"
Researcher Chen Zhiling from the Shanghai Advanced Research Institute, Chinese Academy of Sciences, delivered a presentation titled "Introduction to Proton Therapy Engineering Technology"
Associate Researcher Ruan Shuang from the Institute of Modern Physics, Chinese Academy of Sciences, delivered a presentation titled "Introduction to Engineering Technology for Heavy Ion Therapy"
Professor Lu Xiaoming from the Institute of Ion Medicine, the First Affiliated Hospital of University of Science and Technology of China (USTC), delivered a presentation titled "Physics Work Experience in Registered Clinical Trials of Proton Systems"
Professor Zhang Ye from Cancer Hospital, Chinese Academy of Medical Sciences, delivered a presentation titled "Proton Therapy for Head and Neck and Thoracic Cancers"
Professor Liang Tianjiao from the Institute of High Energy Physics, Chinese Academy of Sciences, delivered a presentation titled "Introduction to Engineering Technology for BCNT Therapy"
Professor Liu Zhigang from Dongguan People's Hospital, the 10th Affiliated Hospital of Southern Medical University, delivered a presentation titled "Advances in BNCT Treatment for Recurrent Head and Neck Cancers"
This training program attracted 300 practitioners—including physicians, medical physicists, and technicians—from oncology centers and radiation oncology departments of medical institutions at all levels nationwide. During the event, experts, scholars, and participants engaged in lively discussions on hot topics such as technological innovation in particle radiotherapy, optimization of clinical care, and construction of an industrial ecosystem. They not only shared cutting-edge academic findings but also built a cross-regional, cross-institutional professional collaboration network—consolidating consensus and pooling strength for the standardized application and high-quality development of China’s particle radiotherapy technology.
After the training, participating experts conducted on-site inspections of the Wuwei Heavy Ion Center. They observed up close the operation of China’s independently developed heavy ion therapy equipment, personally witnessed the full-chain breakthroughs of China’s particle therapy technology from independent innovationto clinical translation, and spoke highly of the center’s achievements in equipment localization, standardization of diagnosis and treatment, and internationalization of services.
In fact, the Wuwei Heavy Ion Center has long been a go-to learning hub for China’s particle medicine field. Colleagues from existing and planned heavy ion-related institutions nationwide have flocked here to draw on its experience. Since the launch of the heavy ion project, over 2,000 government bodies, hospitals, and enterprises—including the Shanghai Proton and Heavy Ion Hospital, Zhejiang Cancer Hospital, and Beijing Tiantan Hospital—have visited to learn firsthand about the center’s best practices in technological R&D, clinical operations, and management. This training course has further amplified the reach of the "Wuwei Experience," disseminating its standardized, systematic approach to particle therapy nationwide.
Preliminary Review: Zhang Jie
Final Review: Zhang Lihong